Desidustat Uses, Dosage, Side Effects and more
Desidustat is under investigation in clinical trial NCT04012957 (Desidustat in the Treatment of Anemia in CKD).
| Trade Name | Desidustat |
| Generic | Desidustat |
| Desidustat Other Names | Desidustat |
| Type | |
| Formula | C16H16N2O6 |
| Weight | Average: 332.312 Monoisotopic: 332.100836243 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
How Desidustat works
The small molecule hypoxia-inducible factor, desidustat, inhibits the prolyl hydrozylase and stimulates erythropoiesis. It is currently being investigated against anemia of inflammation and COVID-19.
